You are here

Article info

Article menu
Immunotherapy biomarkers
Original research
Prognostic model for unresectable hepatocellular carcinoma treated with dual PD-1 and angiogenesis blockade therapy

Authors

  • Zhiqiang Mo Department of Minimally Invasive Intervention, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Ling Lv Department of Minimally Invasive Intervention, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, ChinaDepartment of Radiology, Guangdong Provincial Key Laboratory of Major Obstetric Discases; Guangdong Provincial Clinical Research Center for 0bstetricsc and Gynecology;The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Qicong Mai Department of Minimally Invasive Intervention, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Qiao Li Department of General Surgery, Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Jian He Department of Interventional Radiology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China PubMed articlesGoogle scholar articles
  • Tao Zhang Department of Radiology, Guangzhou Medical University Affiliated Cancer Hospital, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Jingwu Xu Department of Oncology and Peripheral Interventional Radiology, People’s Hospital of Huazhou, Maoming, China PubMed articlesGoogle scholar articles
  • Jiayan Fang Department of Internal Medicine-Oncology, Dongguan Songshan Lake Central Hospital, Dongguan, China PubMed articlesGoogle scholar articles
  • Ning Shi Department of General Surgery, Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Qing Gou Department of Minimally Invasive Intervention, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Xiaoming Chen Department of Minimally Invasive Intervention, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Jing Zhang Department of Minimally Invasive Intervention, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Wenhang Zhuang Department of Minimally Invasive Intervention, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Haosheng Jin Department of General Surgery, Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles

Citation

Mo Z, Lv L, Mai Q, et al
Prognostic model for unresectable hepatocellular carcinoma treated with dual PD-1 and angiogenesis blockade therapy
Journal for ImmunoTherapy of Cancer 2024;12:e008191. doi: 10.1136/jitc-2023-008191
Online issue publication 
January 30, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.